use
vaccin
effect
rel
inexpens
mean
control
infecti
diseas
caus
heavi
econom
loss
livestock
industri
anim
loss
decreas
product
treatment
expens
decreas
carcass
qualiti
howev
vaccin
produc
convent
mean
imperfect
mani
respect
includ
virul
safeti
efficaci
moreov
vaccin
anim
diseas
although
genet
engin
provid
new
way
produc
effect
vaccin
cost
product
veterinari
use
critic
criterion
select
method
product
deliveri
vaccin
cost
effect
product
intrins
abil
enter
cell
made
adenoviru
vector
highli
effici
tool
deliveri
vaccin
antigen
moreov
adenovirus
induc
humor
cellular
immun
respons
express
vaccin
antigen
sinc
nonhuman
adenovirus
speci
specif
develop
anim
specif
adenovirus
vaccin
deliveri
vector
evalu
review
summar
work
relat
develop
bovin
vaccin
deliveri
vehicl
anim
particularli
cattl
adenovirus
adv
nonenvelop
doubl
strand
dna
virus
icosahedr
capsid
symmetri
compos
capsom
genom
size
rang
kb
although
adenovirus
first
identifi
earli
adenoid
human
acut
respiratori
infect
today
serotyp
isol
differ
speci
includ
mammal
bird
reptil
fish
adenovirus
infect
wide
varieti
anim
includ
human
bird
livestock
usual
speciesspecif
adv
propos
cluster
five
phylogenit
distinct
group
name
mastadenoviru
aviadenoviru
atadenoviru
siadenoviru
ichtadenoviru
viru
group
distinct
characterist
genom
structur
overal
genet
organ
member
mastadenoviru
includ
human
adenoviru
hadv
canin
adenoviru
cadv
simian
adenoviru
sadv
bovin
adenoviru
badv
porcin
adenoviru
padv
appear
conserv
mastadenoviru
genom
divid
five
discret
transcript
unit
earli
region
locat
either
end
genom
separ
intern
central
core
region
constitut
late
region
addit
two
delay
earli
transcript
unit
name
pix
despit
genet
conserv
region
highli
diverg
base
structur
transcript
protein
among
differ
member
mastadenovirus
particular
deduc
amino
acid
sequenc
orf
region
show
littl
homolog
correspond
protein
encod
genom
member
mastadenovirus
sinc
protein
involv
viru
cell
interact
viral
gene
express
variat
protein
may
reflect
divers
host
rang
pathogen
potenti
differ
member
mastadenovirus
recent
year
much
attent
focus
evalu
adenovirus
viral
vector
due
abil
infect
divid
nondivid
cell
capac
packag
larg
foreign
gene
rel
eas
produc
high
titer
recombin
cell
cultur
elicit
strong
antigen
specif
cell
respons
lack
virul
although
recombin
hadv
proven
deliv
vaccin
antigen
domest
anim
bird
regulatori
concern
regard
safeti
limit
use
domest
anim
moreov
speci
specif
limit
host
rang
restrict
replic
non
host
speci
http
elsevi
ltd
right
reserv
stabil
nonhuman
adenovirus
led
evalu
anim
poultri
fowl
adenoviru
fadv
specif
adenovirus
vaccin
deliveri
vector
sinc
natur
nonpathogen
viru
restrict
hostrang
grow
high
titer
deliv
intranas
without
affect
meat
qualiti
food
produc
anim
evalu
vaccin
deliveri
vector
anim
includ
cattl
nm
diamet
non
envelop
icosahedr
particl
contain
doubl
strand
dna
genom
genom
base
pair
flank
either
end
bp
invert
termin
repeat
itr
play
key
role
dna
replic
unlik
adenovirus
itr
longer
contain
high
gc
content
like
adenovirus
packag
domain
locat
left
end
viral
genom
overlap
transcript
control
region
region
express
distinct
appear
essenti
packag
though
tata
caat
box
absent
region
left
itr
upstream
start
codon
express
open
read
frame
driven
promot
locat
within
itr
base
transcript
analysi
genom
appear
organ
fig
earli
intermedi
late
region
although
genom
organ
appear
similar
member
mastadenovirus
structur
function
protein
encod
differ
region
appear
differ
initi
attempt
gener
recombin
use
homolog
recombin
madin
darbi
bovin
kidney
mdbk
cell
cotransfect
purifi
genom
transfer
vector
contain
delet
region
ineffici
mostli
unsuccess
due
low
transfect
effici
ineffici
recombin
mdbk
cell
howev
two
improv
name
avail
homolog
recombin
machineri
escherichia
coli
use
bovin
retina
cell
transfect
restrict
enzym
excis
modifi
genom
plasmid
facilit
effici
gener
recombin
recent
effici
time
save
method
gener
recombin
report
transfect
endonucleas
iscei
express
non
bovin
cotton
rat
lung
cell
circular
genom
dna
flank
iscei
recognit
site
isol
replic
compet
contain
partial
delet
small
suggest
region
essenti
replic
fetal
bovin
retina
cell
may
use
foreign
gene
insert
howev
viabl
recombin
larg
delet
could
rescu
suggest
region
essenti
replic
howev
packag
cell
line
express
region
vido
support
replic
bp
delet
fig
complet
region
delet
replicationdefect
contain
insert
kb
foreign
dna
region
delet
could
isol
complement
cell
line
sinc
replicationdefect
vector
undergo
multipl
replic
cycl
therefor
less
like
spread
environ
consid
safer
one
major
concern
regard
use
live
viral
vector
vaccin
anim
releas
potenti
recombin
environ
howev
sinc
replicationincompet
recombin
undergo
abort
infect
level
foreign
gene
express
lower
obtain
use
replicationcompet
region
kb
sinc
region
non
essenti
replic
adenovirus
initi
attempt
result
isol
viabl
recombin
contain
delet
kb
region
although
potenti
insert
capac
delet
vector
kb
insert
kb
foreign
dna
success
gener
viabl
replicationcompet
recombin
foreign
open
read
frame
orf
insert
effici
express
use
upstream
endogen
promot
exogen
promot
howev
insert
foreign
orf
antiparallel
transcript
lead
gener
viabl
recombin
moreov
addit
exogen
consensu
sequenc
polyadenyl
foreign
orf
affect
replic
effici
recombin
lobanov
tikoo
unpublish
data
interestingli
effici
express
rna
viru
requir
addit
intron
consensu
sequenc
polyadenyl
upstream
downstream
respect
gene
sinc
delet
recombin
replic
compet
fig
less
amount
viru
may
requir
induc
protect
immun
respons
first
site
insert
foreign
orf
identifi
transcript
inact
region
start
right
itr
isol
replic
compet
contain
insert
kb
foreign
dna
nucleotid
suggest
region
nonessenti
replic
fig
howev
exogen
promot
consensu
sequenc
polyadenyl
requir
express
foreign
orf
site
potenti
insert
foreign
orf
identifi
transcript
activ
region
isol
replic
compet
contain
delet
nterminu
kb
cterminu
kb
fig
region
suggest
region
essenti
replic
thu
increas
potenti
insert
capac
delet
kb
much
initi
effort
develop
replicationcompet
base
vector
focus
nonessenti
region
earlier
success
express
report
orf
insert
partial
delet
region
suggest
feasibl
util
region
express
foreign
gene
thu
subsequ
express
differ
form
bhv
vaccin
antigen
gd
orf
bvdv
orf
bcv
viru
orf
insert
individu
fulli
delet
region
demonstr
potenti
develop
base
recombin
vaccin
cattl
orf
select
earlier
report
suggest
potenti
bovin
herpesviru
bhv
glycoprotein
gd
bovin
viral
diarrhea
viru
bvdv
glycoprotein
late
l
region
corona
viru
bcv
hemagglutinin
orf
induc
protect
immun
respons
anim
thu
act
vaccin
antigen
report
suggest
cotton
rat
serv
smallanim
model
investig
immun
respons
vector
vaccin
feasibl
use
replicationcompet
recombin
induc
antigen
specif
immun
respons
anim
demonstr
immun
cotton
rat
twice
intranas
three
week
apart
recombin
express
gdgdt
bvdv
protein
one
concern
use
vector
presenc
vari
level
vector
specif
preexist
antibodi
calv
field
address
concern
induct
specif
immun
respons
analyz
calv
contain
signific
level
preexist
specif
neutral
antibodi
result
suggest
intranas
immun
calv
induc
signific
specif
antibodi
respons
presenc
specif
neutral
antibodi
next
use
replicationcompet
effect
vaccin
deliveri
vehicl
test
natur
host
calv
contain
signific
level
preexist
specif
neutral
antibodi
demonstr
induct
protect
immun
respons
challeng
calv
immun
recombin
replicationcompet
express
gdgdt
studi
calv
immun
twice
intranas
four
week
apart
challeng
two
week
later
immun
calv
protect
clinic
diseas
show
shed
reduc
time
thu
speciesspecif
vector
develop
use
induc
mucos
immun
protect
diseas
natur
host
moreov
mucos
intranas
immun
help
bypass
effect
vector
specif
preexist
antibodi
induct
protect
immun
respons
contrast
intratrachealsubcutan
immun
replicationcompet
recombin
express
gdt
effici
intranas
immun
induc
protect
immun
respons
calv
despit
requir
high
dose
replicationdefect
human
adenoviru
base
vector
success
use
induc
protect
immun
respons
anim
poultri
contrast
replicationdefect
express
gdt
appear
effici
induc
protect
immun
respons
calv
could
due
low
amount
replicationdefect
recombin
use
immun
may
adequ
produc
suffici
amount
vaccin
antigen
although
use
high
amount
replicationdefect
vector
may
induc
protect
immun
respons
clave
costeffect
product
vaccin
may
problemat
sinc
veterinari
vaccin
safe
cost
effect
develop
recombin
vector
vaccin
provid
immun
one
pathogen
desir
recent
demonstr
singl
recombin
express
vaccin
antigen
two
respiratori
pathogen
gdt
gg
bovin
respiratori
syncyti
viru
brsv
cattl
could
isol
moreov
two
intranas
immun
four
week
apart
calv
singl
recombin
express
gdt
brsv
gg
induc
signific
neutral
antibodi
brsv
cotton
rat
thu
construct
singl
recombin
multipl
vaccin
antigen
feasibl
induc
viru
specif
immun
protect
multipl
pathogen
calv
sever
recent
studi
experiment
model
demonstr
possibl
bia
immun
respons
requir
administr
recombin
cytokin
along
vaccin
antigen
help
modul
diseas
progress
anim
model
moreov
inocul
replicationdefect
porcin
protect
pig
footandmouth
diseas
fmd
delay
reduc
diseas
sign
cattl
challeng
fmd
viru
howev
despit
avail
differ
bovin
cytokin
gene
studi
report
investig
immunomodul
potenti
known
bovin
bo
cytokin
cattl
demonstr
feasibl
construct
replicationcompet
delet
recombin
virus
express
bovin
fig
panel
ac
fig
panel
b
gene
insert
region
fig
requir
effect
cytokin
modul
immun
respons
best
achiev
vaccin
antigen
cytokin
synthes
cell
end
demonstr
feasibl
construct
replic
compet
delet
recombin
express
antigencytokin
chimera
express
antigenand
cytokin
individu
protein
gdt
singl
mrna
addit
coexpress
gdt
retain
antigen
retain
biolog
activ
henc
construct
evalu
singl
express
two
antigen
vaccin
antigen
cytokin
possibl
sinc
gdgdt
express
recombin
induc
effici
mucos
iga
respons
requir
elimin
shed
immun
calv
evalu
effect
recombin
coexpress
gdt
immunomodulatori
effect
induct
gdt
specif
immun
respons
calv
although
coexpress
modul
gdt
specif
immun
respons
studi
provid
feasibl
deliv
vaccin
antigen
cytokin
potent
adjuv
effect
modul
immun
respons
cattl
although
vector
effici
deliv
vaccin
antigen
respiratori
mucos
surfac
cattl
prospect
oral
deliveri
base
vaccin
help
reduc
indirect
cost
man
power
anim
handl
associ
vaccin
thu
provid
addit
econom
benefit
though
potenti
use
deliv
vaccin
antigen
enter
mucos
surfac
cattl
success
possibl
develop
vector
deliv
vaccin
antigen
differ
mucos
surfac
genet
modif
capsid
protein
techniqu
also
appli
deliv
vaccin
antigen
anim
eg
cat
dog
poultri
test
feasibl
chang
tropism
genet
manipul
major
capsid
protein
fiber
minor
capsid
protein
pix
first
construct
recombin
chimer
fiber
replac
knob
region
fiber
knob
region
fiber
alter
tropism
recombin
second
provid
proof
principl
minor
capsid
protein
pix
use
stabl
insert
longer
polypeptid
expos
surfac
virion
moreov
incorpor
target
ligand
cterminu
pix
enhanc
fiberknob
independ
tropism
pix
base
target
evalu
develop
improv
vector
bovin
vaccin
thu
possibl
exchang
knob
region
fiber
knob
region
adenoviru
fiber
tropism
enter
mucosa
cattl
gener
vector
vaccin
deliv
oral
altern
possibl
develop
recombin
express
chimer
pix
pix
contain
target
ligand
recogn
cell
ileal
peyer
patch
enter
mucosa
although
advanc
recombin
dna
technolog
led
identif
potent
vaccin
antigen
one
impedi
develop
effect
vaccin
appropri
deliveri
vaccin
moreov
develop
new
gener
veterinari
vaccin
need
take
account
number
factor
includ
cost
product
eas
deliveri
safeti
efficaci
develop
use
vaccin
base
vector
system
cost
effect
safe
risk
produc
diseas
addit
vaccin
also
use
erad
program
sinc
infect
vaccin
anim
differenti
interestingli
intranas
inocul
calv
wildtyp
replicationcompet
caus
appar
infect
neglig
number
anim
durat
viru
secret
excret
viru
sinc
restrict
host
rang
isol
healthi
cattl
caus
appar
infect
calv
use
replicationcompet
vector
base
vaccin
cattl
may
major
regulatori
concern
use
field
earlier
report
suggest
oncogen
hamster
rat
embryo
cell
howev
like
adenovirus
known
induc
tumor
format
cattl
natur
host
fact
certain
replic
compet
human
adenovirus
contain
transform
region
alreadi
differ
phase
clinic
trial
certain
cancer
vaccin
use
vaccin
human
base
long
substanti
safeti
record
replicationcompet
human
vaccin
us
militari
replic
compet
adenoviru
base
vaccin
develop
also
expect
safe
replicationcompet
adenovir
vector
dose
spare
effect
provid
advantag
manufactur
also
mimic
natur
wildtyp
infect
induc
arm
immun
system
includ
innat
cellular
humor
mucos
immun
theoret
replic
compet
vaccin
vector
safeti
inactiv
vaccin
improv
efficaci
live
attenu
vaccin
gomezroman
et
al
demonstr
detect
vector
stool
rhesu
macaqu
within
week
vaccin
oral
enter
coat
replic
compet
base
vector
howev
spread
viru
upper
respiratori
tract
detect
clinic
symptom
adenoviru
induc
diseas
observ
week
follow
period
prove
safeti
vector
good
toler
vaccin
anim
phase
clinic
trial
oral
replic
vector
vaccin
influenza
human
also
well
toler
demonstr
good
safeti
profil
low
transmiss
gener
experiment
inocul
human
chimpanze
replicationcompet
adenoviru
vector
proven
safe
similarli
replic
compet
vector
expect
safe
toler
cattl
author
conflict
interest
declar
